sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19
NCT07359482
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Post-COVID
POST-Covid 19
Post-COVID Conditions
Interventions
DRUG:
Fluvoxamine
DRUG:
Placebo
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)